N-formylisonicotinamide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: N-formylisonicotinamide
• 英文别名: N-formylpyridine-4-carboxamide
• 化学式: C₇H₆N₂O₂
• 分子量: 150.137
• InChiKey: SPDZPJSFGXTVRN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  59.1
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  4-吡啶甲酰胺 在 1-丙基磷酸酐 作用下， 以 乙酸乙酯 、 甲苯 为溶剂， 反应 24.0h， 生成 N-formylisonicotinamide
  参考文献：
  名称：

  An efficient method for the preparation of N-formyl-imide via amidine using propylphosphonic anhydride (T3P®)

  摘要：

  An efficient method for the preparation of N-formyl imide via amidine using propylphosphonic anhydride (T3P (R)) has been described. Using this method many aryl, hetero aryl, alkyl as well as amino acid imides were synthesized in high yields. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2015.12.046

文献信息

• Facile access to <i>N</i>-formyl imide as an <i>N</i>-formylating agent for the direct synthesis of <i>N</i>-formamides, benzimidazoles and quinazolinones
  作者：Hsin-Yi Huang、Xiu-Yi Lin、Shih-Yao Yen、Chien-Fu Liang

  DOI：10.1039/d0ob01080d

  日期：——

  N-Formamide synthesis using N-formyl imide with primary and secondary amines with catalytic amounts of p-toluenesulfonic acid monohydrate (TsOH·H2O) is described. This reaction is performed in water without the use of surfactants. Moreover, N-formyl imide is efficiently synthesized using acylamidines with TsOH·H2O in water. In addition, N-formyl imide was successfully used as a carbonyl source in the

  描述了使用N-甲酰酰亚胺与伯胺和仲胺以及催化量的对甲苯磺酸一水合物 (TsOH·H 2 O)合成N-甲酰胺。该反应在水中进行，不使用表面活性剂。此外，使用酰基脒在水中有效地合成了N-甲酰亚胺和TsOH·H 2 O。此外，N-甲酰酰亚胺成功地作为羰基源用于苯并咪唑和喹唑啉酮衍生物的合成。使用N对胺进行N-甲酰化的显着特征-甲酰酰亚胺包括操作简单、无氧化剂和无金属条件、结构多样的产品以及易于适用于克级操作。
• BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE
  申请人：Fujita Takashi

  公开号：US20130165446A1

  公开（公告）日：2013-06-27

  The present invention addresses the problem of finding a compound having both PPAR activation activity and angiotensin receptor antagonistic activity. The present invention is a benzo- or pyrido-imidazole derivative represented by general formula (I), a pharmaceutically acceptable salt thereof, or a ester or amide thereof (where A is biphenyl methyl-imidazolyl, biphenyl methyl-benzimidazolyl, or the like, B is divalent benzimidazolyl or the like, C is carboxyl or the like, E is divalent phenyl, naphthyl, or the like, G is a dangling bond, oxygen, or the like, Q is oxygen or sulfur, n is an integer from 1 to 6, p is an integer from 1 to 6, V is a dangling bond, oxygen, or the like, and R is hydrogen, alkyl, or the like).

  本发明解决了寻找既具有PPAR激活活性又具有血管紧张素受体拮抗活性的化合物的问题。本发明是一种由通式（I）表示的苯并或吡啶-咪唑衍生物，其药学上可接受的盐，或其酯或酰胺（其中A是联苯甲基咪唑基，联苯甲基苯并咪唑基或类似物，B是二价苯并咪唑基或类似物，C是羧基或类似物，E是二价苯基，萘基或类似物，G是悬键，氧或类似物，Q是氧或硫，n是从1到6的整数，p是从1到6的整数，V是悬键，氧或类似物，R是氢，烷基或类似物）。
• BENZO- OR PYRIDO-IMIDAZOLE DERIVATIVE
  申请人：Fujita, Takashi

  公开号：EP2581373A1

  公开（公告）日：2013-04-17

  The present invention addresses the problem of finding a compound having both PPAR activation activity and angiotensin receptor antagonistic activity. The present invention is a benzo- or pyrido-imidazole derivative represented by general formula (I), a pharmaceutically acceptable salt thereof, or a ester or amide thereof (where A is biphenyl methyl-imidazolyl, biphenyl methyl-benzimidazolyl, or the like, B is divalent benzimidazolyl or the like, C is carboxyl or the like, E is divalent phenyl, naphthyl, or the like, G is a dangling bond, oxygen, or the like, Q is oxygen or sulfur, n is an integer from 1 to 6, p is an integer from 1 to 6, V is a dangling bond, oxygen, or the like, and R is hydrogen, alkyl, or the like).

  本发明要解决的问题是找到一种既具有 PPAR 激活活性又具有血管紧张素受体拮抗活性的化合物。本发明是通式（I）代表的苯并咪唑或吡啶咪唑衍生物、其药学上可接受的盐或其酯或酰胺（其中 A 是联苯甲基咪唑基、联苯甲基苯并咪唑基或类似物，B 是二价苯并咪唑基或类似物、C 是羧基或类似物，E 是二价苯基、萘基或类似物，G 是悬键、氧或类似物，Q 是氧或硫，n 是 1 到 6 的整数，p 是 1 到 6 的整数，V 是悬键、氧或类似物，R 是氢、烷基或类似物）。
• Topical localized isoxazoline formulation
  申请人：Intervet Inc.

  公开号：US10864195B2

  公开（公告）日：2020-12-15

  This invention provides topical localized formulations comprising an isoxazoline compound and a pharmaceutically or veterinary acceptable liquid carrier vehicle comprising N,N-diethyl-3-methylbenzamide as a solvent and an improved method for controlling, and preventing parasite infestation in animals.

  本发明提供了局部外用制剂，包括异噁唑啉化合物和一种药用或兽用可接受的液体载体，其中N,N-二乙基-3-甲基苯甲酰胺是一种溶剂，还提供了一种控制和预防动物寄生虫感染的改进方法。
• Solid Oral Pharmaceutical Compositions for Isoxazoline Compounds
  申请人：Intervet Inc.

  公开号：US20170100377A1

  公开（公告）日：2017-04-13

  A solid oral pharmaceutical composition for delivery of a pharmaceutically acceptable active ingredient to an animal where the composition comprises an isoxazoline compound, a solvent and an excipient, a process for the manufacture of such solid oral pharmaceutical composition and a method of controlling a parasite infection administering such solid oral pharmaceutical composition.